Güttler F, Hansen G
Ann Clin Biochem. 1977 May;14(3):124-34. doi: 10.1177/000456327701400125.
Abnormalities related to the hydroxylation of phenylalanine to tyrosine are classified into three phenotypes based on the amount of dietary phenylalanine tolerated to keep serum phenylalanine within therapeutic levels, i.e., 180-425 micronmol/l(3-7 mg/100 ml) : (1) Classical phenylketonuria (PKU) tolerating approximately 17% of a normal intake of phenylalanine or approximately 0.12 mmol per kg body weight; (2) mild PKU with a tolerance some 50% higher; and (3) persistent hyperphenylalaninaemia (HPA) with serum phenylalanine values within therapeutic levels on a daily intake of greater than or equal to 0.7 mmol phenylalanine per kg body weight. Oral phenylalanine loading was performed on 100 heterozygotes for these abnormalities and 33 normal homozygotes. The slope of the rise in serum tyrosine multiplied by the maximum serum tyrosine concentration over the maximum phenylalanine concentration was the most powerful discriminant (D/-s, 3.54; overlapping 2.4%). Three heterozygous phenotypes were distinguished by this discriminant, and a significant correlation was observed between the phenotypic combination of the parents and the phenotype of their affected child. In particular, parents of children with classical PKU were clearly distinguished from heterozygotes for the other two abnormalities.
与苯丙氨酸羟化生成酪氨酸相关的异常情况,根据维持血清苯丙氨酸在治疗水平(即180 - 425微摩尔/升,或3 - 7毫克/100毫升)所需耐受的膳食苯丙氨酸量,分为三种表型:(1)经典型苯丙酮尿症(PKU),能耐受正常苯丙氨酸摄入量的约17%,或约0.12毫摩尔/千克体重;(2)轻度PKU,耐受性约高50%;(3)持续性高苯丙氨酸血症(HPA),每日摄入大于或等于0.7毫摩尔苯丙氨酸/千克体重时,血清苯丙氨酸值处于治疗水平。对100名这些异常情况的杂合子和33名正常纯合子进行了口服苯丙氨酸负荷试验。血清酪氨酸升高斜率乘以最大血清酪氨酸浓度与最大苯丙氨酸浓度之比是最有效的判别指标(D/-s,3.54;重叠率2.4%)。通过该判别指标区分出三种杂合子表型,且观察到父母的表型组合与其患病子女的表型之间存在显著相关性。特别是,经典型PKU患儿的父母与其他两种异常情况的杂合子有明显区别。